Based in the United Kingdom, Haleon makes consumer health care products, including Advil, Centrum Multivitamin and Aquafresh Toothpaste.

Haleon, a global consumer health company, is investing $54.2 million to upgrade its research & development (R&D) facility in Richmond, Virginia. The modernization will enable the company to expand ...

Zoom in: Haleon's Richmond facility is the company's R&D Center of Excellence, specializing in formulation development, microbiology, product stability, packaging design, and consumer science ...

RICHMOND, Va. — Haleon, a global company behind home healthcare products like Advil, Tums and Aquafresh, announced Monday its plan to upgrade its Richmond research and development facility.

RICHMOND, Va. (WRIC) — Haleon, a global consumer health company behind products like Advil, Aquafresh and Polident, announced a $54.2 million upgrade to its Richmond facility. On Monday ...

Consumer health care company Haleon PLC plans to invest $54.2 million to upgrade its research and development facility in Richmond’s Northside. Virginia Gov. Glenn Youngkin announced the British ...

The UK-based pharmaceutical company Haleon will invest $54.2 million to upgrade its R&D facility in Richmond, which has helped birth or grow products such as Advil, Emergen-C and Robitussin.

Pharmaceutical company Haleon will invest $54.2 million to upgrade its research and development facility in Richmond and launch an internship program in partnership with state government and Virginia ...

The expansion was announced in a press conference held on Monday, Jan. 27, detailing how Haleon, a global health company, plans to invest $54.2 million for upgrades to the Richmond facility.

The UK-based pharmaceutical company Haleon will invest $54.2 million to upgrade its R&D facility in Richmond, which has helped birth or grow products such as Advil, Emergen-C and Robitussin.

The modernization will enable the company to accommodate innovative technologies and expand its research capabilities. Governor Youngkin met with Haleon leadership in London in July 2024 to discuss ...